{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:01:21Z","timestamp":1792454481203,"version":"4.5.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.kint.2019.07.018","type":"journal-article","created":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T01:58:40Z","timestamp":1566266320000},"page":"156-162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":119,"title":["Kidney biopsy\u2013based management of maintenance immunosuppression is safe and may ameliorate flare rate in lupus nephritis"],"prefix":"10.1016","volume":"97","author":[{"given":"Ana","family":"Malvar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Alberton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Lococo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matias","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haikady N.","family":"Nagaraja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad H.","family":"Rovin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2019.07.018_bib1","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1002\/art.38790","article-title":"Treatment of lupus nephritis with abatacept: the abatacept and cyclophosphamide combination efficacy and safety study","volume":"66","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.kint.2019.07.018_bib2","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/art.34359","article-title":"Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the lupus nephritis assessment with rituximab study","volume":"64","author":"Rovin","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.kint.2019.07.018_bib3","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1681\/ASN.2008101028","article-title":"Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis","volume":"20","author":"Appel","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2019.07.018_bib4","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2215\/CJN.05780616","article-title":"Update on lupus nephritis","volume":"12","author":"Almaani","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2019.07.018_bib5","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.2215\/CJN.02670409","article-title":"Oral cyclophosphamide for lupus glomerulonephritis: an under-utilized therapeutic option","volume":"4","author":"McKinley","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2019.07.018_bib6","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2215\/CJN.05040513","article-title":"Renal flare as a predictor of incident and progressive CKD in patients with lupus nephritis","volume":"9","author":"Parikh","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2019.07.018_bib7","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1093\/ndt\/gfv296","article-title":"Histologic versus clinical remission in proliferative lupus nephritis","volume":"32","author":"Malvar","year":"2017","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.kint.2019.07.018_bib8","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2014-000018","article-title":"Role of early repeated renal biopsies in lupus nephritis","volume":"1","author":"Zickert","year":"2014","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.kint.2019.07.018_bib9","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/ndt\/gfr517","article-title":"Strategy for second kidney biopsy in patients with lupus nephritis","volume":"27","author":"Alsuwaida","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2019.07.018_bib10","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.kint.2018.05.021","article-title":"A\u00a0prospective observational cohort study highlights kidney biopsy findings of lupus nephritis patients in remission who flare following withdrawal of maintenance therapy","volume":"94","author":"De Rosa","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2019.07.018_bib11","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/1756-185X.13274","article-title":"Outcome and predictors of renal survival in patients with lupus nephritis: comparison between cyclophosphamide and mycophenolate mofetil","volume":"21","author":"Joo","year":"2018","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.kint.2019.07.018_bib12","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1177\/0961203313476357","article-title":"Predictors of renal relapse in Korean patients with lupus nephritis who achieved remission six months following induction therapy","volume":"22","author":"Moon","year":"2013","journal-title":"Lupus"},{"key":"10.1016\/j.kint.2019.07.018_bib13","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.3899\/jrheum.170226","article-title":"Longterm data on disease flares in patients with proliferative lupus nephritis in recent years","volume":"44","author":"Yap","year":"2017","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.kint.2019.07.018_bib14","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1177\/0961203317726376","article-title":"Sustained complete renal remission is a predictor of reduced mortality, chronic kidney disease and end-stage renal disease in lupus nephritis","volume":"27","author":"Pakchotanon","year":"2018","journal-title":"Lupus"},{"key":"10.1016\/j.kint.2019.07.018_bib15","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1136\/annrheumdis-2017-212732","article-title":"Changing patterns in clinical-histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis","volume":"77","author":"Moroni","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.kint.2019.07.018_bib16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.autrev.2017.11.003","article-title":"Can we withdraw immunosuppressants in patients with lupus nephritis in remission? An expert debate","volume":"17","author":"Moroni","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.kint.2019.07.018_bib17","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/0002-9343(83)90338-8","article-title":"Prognostic factors in lupus nephritis: contribution of renal histologic data","volume":"75","author":"Austin","year":"1983","journal-title":"Am J Med"},{"key":"10.1016\/j.kint.2019.07.018_bib18","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1523-1755.2004.00443.x","article-title":"The classification of glomerulonephritis in systemic lupus erythematosus revisited","volume":"65","author":"Weening","year":"2004","journal-title":"Kidney Int"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253819308166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253819308166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:53:44Z","timestamp":1758761624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253819308166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0085253819308166"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2019.07.018","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kidney biopsy\u2013based management of maintenance immunosuppression is safe and may ameliorate flare rate in lupus nephritis","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2019.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}